47 results
424B5
ENLV
Enlivex Therapeutics Ltd
30 Dec 22
Prospectus supplement for primary offering
4:01pm
that the duration of the transaction is reasonable given the circumstances related thereto.
Arrangements regarding the terms of engagement
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
5 Oct 22
Notice of Annual General Meeting of Shareholders
3:00pm
, such that 25% of the options shall vest on each of the four anniversaries of the date of grant, subject to Mr. Novik’s continued engagement … of the three anniversaries of the date of grant, subject to Mr. Novik’s continued engagement by the Company on each applicable vesting date.
In each case
F-3
6qta17u0437
29 Apr 22
Shelf registration (foreign)
8:14am
6-K
EX-99.1
zoq6r2et7nokf
30 Sep 21
Annual and Extraordinary General Meeting of Shareholders
8:01am
6-K
EX-10.1
q9mmdib90s7q159 3z
12 Feb 21
Enlivex Announces Closing of Previously Announced Bought Deal Offering of Approximately $46.0 Million Ordinary Shares
5:17pm
6-K
EX-1.1
hfz58v625te 3d5js
12 Feb 21
Enlivex Announces Closing of Previously Announced Bought Deal Offering of Approximately $46.0 Million Ordinary Shares
5:17pm
424B5
2752wkjcuntmly 2o
10 Feb 21
Prospectus supplement for primary offering
5:22pm
424B5
j9ojbnrr9xc1ld74
9 Feb 21
Prospectus supplement for primary offering
4:56pm
6-K
EX-10.1
us7yjg9qzq5u7sx
22 Oct 20
Report of Foreign Private Issuer
8:47am
424B5
0jairpu49
22 Oct 20
Prospectus supplement for primary offering
8:45am
6-K
EX-99.1
dqf9u4
19 May 20
Annual and Extraordinary General Meeting of Shareholders
8:04am
6-K
EX-4.2
jwrfpq
5 Mar 20
Report of Foreign Private Issuer
8:16am
6-K
EX-5.2
789v pqc4zw2
5 Mar 20
Report of Foreign Private Issuer
8:16am